Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (RARE) Balance Sheet

1,317 Followers

Ultragenyx Pharmaceutical Balance Sheet

Ultragenyx Pharmaceutical's total assets for Q3 2026 were $1.19B, a decrease of 6.09% from the previous quarter. RARE total liabilities were $1.56B for the fiscal quarter, a 0.52% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.53B$ 1.50B$ 1.49B$ 1.55B$ 1.52B
$ 1.60B$ 1.24B$ 1.22B$ 1.19B$ 599.84M
$ -73.00M$ 262.30M$ 275.41M$ 352.49M$ 922.56M

Currency in USD

Ultragenyx Pharmaceutical Liabilities to Assets

0800M1.6B2.4B0 %40 %80 %120 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets